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A b S t r A c t
infections caused by Staphylococcus aureus are a major problem in hospitals. the 
multidrug resistance and the nasal carriage of S. aureus play a key role in the epidemic 
of these infections. in this prospective study, 160 S. aureus strains were isolated from 
pathological samples of patients (79 cases) and nasal swabs (81) of cases and controls 
from January to July 2007. the susceptibility to 16 antibiotics, including cefoxitin, was 
determined by the agar diffusion method, and methicillin resistance was confirmed 
by amplifying the mecA gene by polymerase chain reaction (Pcr). the prevalence of 
methicilin-resistant S. aureus (MrSA) was high in the burns (57.7%) and dermatology 
(39.4%) wards, and the MrSA strains isolated were extremely multi-resistant, but all of 
them were still susceptible to vancomycin. the rate of S. aureus nasal carriage was high 
in both cases and controls, in state, MrSA nasal carriage was more common among 
people infected with S. aureus. 
Brief Communication
Epidemiology of Staphylococcus aureus infections and 
nasal carriage at the Ibn Rochd University Hospital Center, 
Casablanca, Morocco
Sanaâ Bouhali Zriouila,b, Mohammed Bekkalib, Khalid Zeroualia,*
aLaboratory of Microbiology, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Casablanca, Morocco 
bFaculty of Sciences Ain Chock, University Hassan II, Casablanca, Morrocco
*Corresponding author at: Laboratory of Microbiology, ibn rochd University Hospital, faculty of Medecine and Pharmacy, 19 Street  
 tarik bnou Zyad, casablanca, Morocco 
 E-mail address: kzerouali.zerouali@gmail.com (Khalid Zerouali)
Introduction
S. aureus infections constitute a major health care problem because 
this pathogen has developed resistance to most antibiotics 
introduced in antibiotherapy.1 Moreover, the nasal carriage of 
S. aureus/methicilin-resistant S. aureus (MrSA) is recognized as 
a risk factor for the acquisition of an endogenous infection and 
plays an important role in the spread of this pathogen not only in 
the hospital care units but in the community as well.2
Data exist for different countries regarding S. aureus/MrSA 
infections, but in Africa and developing countries only a few 
reports are available. this study was conducted in order to 
better understand the epidemiology of S. aureus/MrSA at the 
University Hospital center ibn rochd (UHcir) by determining 
the rate of MrSA in different risk departments, establishing the 
resistance profile of S. aureus against various antibiotic 
families, and studying the nasal carriage of S. aureus in 
infected patients, as well as its role in the acquisition of 
S. aureus infection through a case-control study.
Materials and methods
this study was established at the UHcir casablanca, a 1,609-bed 
teaching hospital with three major branches (administrative, 
clinical, and pediatric). there are eight intensive care units 
(icUs), with 83 beds. the UHcir receives approximately 100,000 
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patients for consultations and 32,000 admissions per year, with 
an estimated 210,000 patient/days. 
this prospective study was conducted over a period of six 
months (January-July 2007). During this period, all strains of 
S. aureus isolated from various samples received from the 
target units (pediatric, dermatology, burns icUs) at 
the UHcir were collected. only one strain per patient was 
chosen (the most resistant one, and isolated from the most 
invasive sample).
the study focused on the services of pediatrics, dermatology, 
burns, and icUs. these services were of interest because they 
recorded the highest prevalence of MrSA in UHcir during the 
last three years, according to the laboratory database.
for each case patient (hospitalized in the target units 
and from whom an S. aureus strain was isolated), a control, 
present in the same service at the same date and with no 
S. aureus infection was selected. Patient cases and controls 
were subjected to a nasal swab to search for nasal carriage 
of S. aureus after their consent. 
Patients without completed standardized questionnaire and 
informed consent for the nasal carriage were excluded from 
the study. 
Isolation and identification of S. aureus strains
the isolation and identification of S. aureus were performed 
according to the conventional methods of bacteriology: seeding 
on columbia nalidixic acid (cnA) agar, colonial morphology, 
Gram stain, catalase, and tube coagulase test.
Antibiogram
the antibiogram was performed by the agar diffusion method 
according to the guidelines of the cASfM (Antibiogram 
committee of the french Microbiology Society, 2007 edition). 
resistance to methicillin was evaluated through a cefoxitin disk 
loaded at 30 µg. the strains with diameter less than 25 mm 
were subjected to polymerase chain reaction (Pcr) of mecA gene.
resistance phenotypes associated to isolated strains were 
determined by other antibiotics: kanamicin 30 iU, tobramicin 
10 µg, gentamicin 15 µg, erythromycin 15 iU, spiramycin 100 µg, 
lincomycin 15 µg, pristinamycin 15 µg, pefloxacin 5 µg, 
tetarcycline 30 iU, minocycline 30 iU, fusidic acid 10 µg, rifampin 
30 µg, fosfomycin 50 µg, trimethoprim sulfamethoxazol 
(cotrimoxazol) 1.25 (23.75) µg, and vancomycin 30 µg.
the automated reading and interpretation was performed 
using osiris (osiris PLc biorad®). intermediate strains are 
considered resistant.
Quality control was carried out through the S. aureus 
strain Atcc 25923 provided by the laboratory of the national 
reference center for Staphylococci (cnrS) in Lyon, france.
Detection of mecA gene
Deoxyribonucleic acid (DnA) of S. aureus strains was extracted 
from a young culture (brain heart broth beef incubated for 
18-24h at 37°c) by phenol/chloroform method.3 the extracted 
DnA was used as template for searching mecA gene using the 
protocol described by Murakami and al.4
Results
Staphylococcus aureus infections
Prevalence and epidemiology
During the period of the study, the laboratory isolated 194 
strains of S. aureus from patients in the target units. only 
40.7% of those patients met the inclusion criteria; as a result, 
79 strains of the isolated pathogen S. aureus were studied. the 
distribution of these strains was as follows: 41.8% from patients 
in the dermatology department, 32.9% in the burns service, 
21.5% in icUs, and 3.8% in the pediatric ward. in the majority 
of cases (70.9%) strains were isolated from skin samples and 
surgical wounds; in 16.4%, from respiratory secretions; and in 
8.9%, from bacteraemia. only two strains were isolated from 
catheter and one from pleural fluid (table 1).
the overall prevalence of MrSA in the hospital in 2007 
was 18.4%.
Sensitivity to antibiotics
MRSA
Among the 79 strains isolated from pathological samples 
received from target units, 28 were resistant to methicillin 
(35.4%). these strains showed a multidrug-resistant profile; 
in fact, 27 of them (96.4%) were resistant to aminoglycosides, 
fluoroquinolones, and tetracycline. Moreover, 25 strains (89.3%) 
were also resistant to rifampin (table 2).
MrSA strains were also characterized by the phenotypes 
kanamycin-tobramycin-gentamycin resistant (KtG) and 
macrolides-lincosamides-streptogamines b (MLSb). MLSb 
phenotypes divided the resistance profiles into two major 
profiles; the inducible MLSb profile observed in 18 strains 
(64.3%), and the lincosamides (L) phenotype observed in nine 
strains (32.1%) (table 3).
Methicillin-sensitive S. aureus (MSSA)
MSSA strains represented 64.5% (51 strains) of total pathogen 
S. aureus studied. the wild profile was observed in only 6% 
of the total strains, while strains with isolated resistance to 
penicillin G was the most frequently observed, with a rate of 
55%. the overall rate of resistance to penicillin G was 90.2%, 
and only 6% for erythromycin, pefloxacin, and kanamycin. 
relatively higher resistance rates were observed for tetracycline 
(29.5%), minocycline (15.7%), and fusidic acid (13.7%).
A statistical comparison of rates of antibiotic resis- 
tance between MrSA and MSSA showed a significant difference 
(p < 0.01) for all the antibiotics tested, except for pristinamycin, 
vancomycin, and fosfomycin, which were 100% active against 
the two groups of S. aureus (table 2).
Nasal carriage of S. aureus in patients (cases and controls)
Rate of S. aureus and MRSA carriage
the number of patients (cases) was 79, and 47 patients met the 
inclusion criteria as controls. nasal carriage was conducted 
among these 126 patients (cases and controls). A total of 81 
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Pathological samples  
n = 79
Nasal swabs 
n = 81
 
 
Cutaneous 
and surgical 
wound
Respiratory 
secretions 
Bacteraemia 
 
Catheter 
 
Pleural  
fluid 
Total 
 
Cases  
n = 79 
Controls  
n = 47 
p 
 
S. aureus 56 (70.9) 13 (16.4) 7 (8.9) 2 (2.5) 1 (1.3) 79 (100) 56 (70.9) 25 (53.2) nS
MSSA 34 13 3 - 1 51 (64.5) 27 (34.2) 18 (38.3) nS
MrSA 22 - 4 2 - 28 (35.4) 29 (36.7) 7 (14.9) < 0.01
nS, not significant; MSSA, methicilin-sensitive S. aureus; MrSA, methicilin-resistant S. aureus.
Table 1 - Number (%) of S. aureus strains isolated from various pathological samples and nasal swabs (nasal carriage rate)
Antibiotics            Number of strains (%) p
 MRSA  
n = 28 
MSSA  
n = 51
 
Penicillin G 28 (100) 46 (90.2) < 0.01
Kanamycin 27 (96.4) 2 (3.9) < 0.01
tobramycin 27 (96.4) 0 < 0.01
Gentamycin 27 (96.4) 0 < 0.01
Erythromycin 18 (64.3) 3 (5.9) < 0.01
Lincomycin 9 (32.1) 0 < 0.01
fusidic acid 18 (64.3) 7 (13.7) < 0.01
Pefloxacin 27 (96.4) 3 (5.9) < 0.01
tetracycline 28 (100) 15 (29.4) < 0.01
Minocycline 26 (96.4) 8 (15.7) < 0.01
rifampin 25 (89.3) 0 < 0.01
trimethoprim sulfamethoxazol (cotrimoxazol) 19 (67.9) 0 < 0.01
Pristinamycin 0 0 -
fosfomycin 0 0 -
Vancomycin 0 0 -
-, indeterminate value; MSSA, methicilin-sensitive S. aureus; MrSA, methicilin-resistant S. aureus.
Table 2 - Resistance rate associated to MRSA and MSSA isolated from pathological samples received from target units at 
the university hospital Ibn Rochd in Casablanca, Morocco
Antibiotype profile Pathological samples 
n = 28
Nasal carriage 
n = 36
Total  
n = 64 (%)
P-K-t-G-E*-Pef-te-Mno-rif-tsx-fuA 14 16 30 (46.9)
P-K-t-G-L**-Pef-te-Mno-rif 8 13 21 (32.8)
P-E*-Pef-te-Mno-rif-tsx-fuA 1 3 4 (6.3)
P-K-t-G-E*-Pef-te-rif-tsx-fuA 2 1 3 (4.7)
P-K-t-G-E*-Pef-te-Mno-tsx-fuA 1 1 2 (3.1)
P-K-t-G-L**-Pef-te-rif 1 1 2 (3.1)
K-t-G-te-Mno-tsx 1 1 2 (3.1)
P, penicillin G; K, kanamycin; t, tobramycin; G, gentamycin; L, lincomycin; E, erythromycin; Pef, pefloxacin; te, tetracycline; Mno, minocycline; 
rif, rifampin; tsx, trimethoprim sulfamethoxazol (cotrimoxazole); fuA, fusidic acid; MrSA, methicilin-resistant S. aureus. * inductible 
macrolides-lincosamides-streptogamines b (MLSb) phenotype, ** L phenotype.
Table 3 - Resistance profiles of MRSA strains from pathological samples and nasal swabs of patients in dermatology 
and burns wards at the University Hospital Ibn Rochd in Casablanca, Morocco
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strains of S. aureus were isolated (from nasal swab of cases and 
controls), including 36 strains of MrSA (44.4%). 
the carriage rate of S. aureus was high: 70.9% for cases 
versus 53.2% for controls. for MSSA nasal carriage rate, the 
difference between cases (34.2%) and controls (38.3%) was not 
significant (p > 0.05). interestingly, the MrSA nasal carriage 
rate was significantly higher among cases: 36.7% versus 14.9% 
in controls (p < 0.01) (table 1).
Sensitivity to antibiotics
the study of different profiles of resistance related to MrSA 
strains isolated from nasal swab samples of case and control 
patients showed multidrug resistance to the different 
antibiotics tested. this result matches with the finding 
concerning MrSA strains isolated from pathological samples. 
the frequency and distribution of the major resistance profiles 
of nasal carriage S. aureus strains are also comparable with 
those from the pathological samples (table 3).
Discussion
in the present study, many reasons led to the exclusion of some 
case patients, such as incomplete standardized questionnaire, 
refusal of some patients to sign the informed consent for nasal 
swab, and discharge of many patients from the target units. 
for controls, there were some difficulties in finding patients 
hospitalized in the same period as case patients, which 
justifies the number of control patients included in this study.
the prevalence of MrSA at the UHcir of casablanca has 
increased from 14.4% to 23.4% between 2000 and 2002.5,6 
this increase is mainly due to high rates of MrSA reported 
in the icUs in 2002. in 2007 this rate decreased to 18.4%, 
due to better application of the hospital hygiene measures 
recommended by the committee for the fight Against 
nosocomial infections (cLin). the rate of MrSA reported 
at the UHcir is comparable to the rates reported in 
tunisia, and it is still low in comparison with the rates 
in Algeria, Egypt, and Jordan.7
in this hospital, the rate of MrSA was higher in the 
dermatology and burns departments than in the icUs. 
this finding is a result – as mentioned before – of an 
efficient hygiene policy in the icUs. the prevalence 
in the dermatology and burns wards was 39.4% and 57.7%, 
respectively. comparable high values have been reported 
in the literature for burn patients in several countries, 
notably in African countries such as tunisia, Libya, 
and South Africa.8-10 the damaged cutaneous barrier of 
these patients contributes to the development of such 
infections.
Susceptibility pattern of S. aureus 
MRSA
the mechanism of resistance to methicillin in S. aureus is 
mainly due to the production of the modified protein PbP2a 
(penicillin-binding protein 2a) encoded by the mecA gene 
which is carried in the mobile genetic element Sccmec 
(Staphylococcal cassette chromosome mec).11 Apart from 
this main mechanism, there are others that remain far less 
common, such as the hyperproduction of beta-lactamase 
observed in borderline-resistant S. aureus (borSA), and the 
presence of a modified PbP in the modified-resistant S. aureus 
(MoDSA).12 in this series, all MrSA strains carried the mecA 
gene and were resistant via PbP2a production. 
Multidrug resistance of MrSA strains were well 
documented several years ago;1 however, the situation in 
Europe, Asia, and America is changing, with the emergence of 
MrSA strains with reduced susceptibility to antibiotics since 
the 1990s.13 interestingly, in this hospital all MrSA strains 
had the former multi-resistant character. the strains were 
resistant at least to six antibiotics other than beta-lactams, 
and several resistance phenotypes have been identified, 
namely: KtG phenotype, inducible MLSb phenotype, and 
L phenotype.
the MLSb inducible strains were isolated mostly in the 
dermatology ward, but also in the burns ward. they were 
associated with resistance to cotrimoxazole, rifampin, 
and fusidic acid, unlike L phenotype strains, which were 
sensitive to these antibiotics. the MLSb phenotype was 
widely reported in several countries such as South Africa, 
india, and Poland.14-16 
in the present study, the rate of resistance to cotrimoxazole, 
fusidic acid, and rifampin are high compared with values 
reported previously in Morocco.6,17 However, the same 
values have been reported in some African countries such as 
ivory coast, Senegal, and cameroon.5 contrariwise, fosfomycin, 
pristinamycin, and glycopeptides remain as active molecules 
against the MrSA strains.
the multiresistant character of MrSA observed in the present 
study limits the choice of antibiotics for treatment. in hospitals, 
vancomycin remains the suitable antibiotic for the treatment 
of MrSA infections. However, dissemination of glycopeptide 
resistant strains is a concern, especially with the isolation of 
some strains with reduced susceptibility to vancomycin.18 Given 
this situation, it is interesting to point out the importance of the 
introduction and marketing of other active molecules against 
MrSA in Morocco, such as fosfomycin.19
MSSA 
the rate of resistance to penicillin of the MSSA strains isolated 
in the present study was at least 90%, this finding is consistent 
with data from Lowy et al., where over 90% of strains of 
S. aureus have become resistant to penicillin by penicillinase 
production.20
resistance to tetracycline was 29.4%, and 13.7% for fusidic 
acid. fusidic acid resistance was especially high in the 
dermatology ward, reaching 30%. this relatively high value 
can be explained by the large spectrum of this antibiotic and 
its widespread use in dermatology units.21
Nasal carriage of S. aureus
nasal carriage plays an important role for the transmission, 
autoinfection, and cross infection in hospital and also in 
the community. Since the 1950s, several authors have 
demonstrated the role of S. aureus carriage in the acquisition 
of infection with S. aureus/MrSA.22 
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this study showed that the carriage rate of MSSA through 
patients is comparable to that seen in control patients (non-
significant difference). this can be explained by the high rate 
of carriage of S. aureus in both case patients and controls in this 
hospital. on the other side, the analysis of MrSA nasal carriage 
between case patients and controls showed that carrying MrSA 
can be considered as a risk factor for developing S. aureus 
infection (significant difference); this result is consistent with 
the literature data.23,24
this carriage study shows also a significant movement of 
S. aureus in both controls and infected patients with S. aureus, 
while the carriage of MrSA is more common among people 
infected with S. aureus. these patients constitute a potential 
source of contamination, and the risk of endogenous infections 
is significant for this population. this is supported by the 
similarity between the resistance patterns of strains isolated 
in pathological samples and those of nasal carriage. the study 
of the nasal carriage in the nursing staff and the application of 
molecular typing methods such as the Sccmec typing, pulsed 
field gel electrophoresis (PfGE) and multi locus sequence 
typing (MLSt) are also important to better understand the role 
of nasal carriage in infection.
Conclusion 
the rate of MrSA in the burns ward and in the dermatology 
ward at the UHcir was high, and the strains isolated were 
characterized by their multi-resistance to antibiotics and the 
differential repartition of MLSb phenotype between these two 
wards. Even if the rate of nasal carriage of MSSA is high, it does 
not represent a risk factor for S. aureus infection. However, 
MrSA is recognized as a potential risk factor for developing 
S. aureus infection in this hospital. it is important in this case 
to establish a policy to fight against the spread of this pathogen 
(MrSA), taking into account the important role of nasal carriage 
of MrSA in this epidemiology. 
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